|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
Experimental sepsis induces disturbances in microcirculatory flow and nutrient exchange that may result in impaired tissue oxygenation. Volume resuscitation is a principal clinical intervention in patients with sepsis. Nitric oxide (NO) has been implicated in the pathophysiology of endotoxemia, but few data exist concerning the effects of either NO synthase inhibition (NOSi) or volume resuscitation on microvascular regulation and tissue oxygenation. Amperometric measurements were made of skeletal muscle (tissue) oxygen tension (PtO2) and its response to changes in fraction of inspired oxygen (FIO2) in rats rendered endotoxemic. Simultaneous measurements were made of systemic hemodynamic indices and arterial blood gas tensions. At normal PaO2, PtO2 in endotoxemic animals was significantly lower than in control animals, with marked attenuation of the response to increasing FIO2. These changes were associated with significant metabolic acidemia. In volume-resuscitated endotoxemic rats, PtO2 and blood pH were unchanged. A significant reduction in the PtO2 response to hyperoxia was observed in animals treated with the NOS inhibitor NG-nitro-L-arginine methyl ester (L-NAME), an effect not reversed by fluid resuscitation. These data suggest that significant tissue hypoxia and abnormal microvascular control occur in endotoxemia. Volume resuscitation can reverse the changes in PtO2, whereas nitric oxide synthase (NOS) inhibition has deleterious effects on muscle PtO2 in both control and endotoxemic animals.
| |
INTRODUCTION |
|---|
|
|
|---|
Sepsis and its related syndromes develop frequently in hospitalized patients, with an associated mortality of 10 to 20%. In the presence of circulatory failure, this figure rises to over 60% and may account for up to 200,000 deaths per annum in the United States alone (1). Most patients succumb to a multiple organ dysfunction syndrome (MODS) rather than hypotension per se (2), but the reasons for this are not clear. Sepsis is known to disrupt microcirculatory flow and nutrient exchange, and an impaired response to endogenous and exogenous pressor agents is often reported (3). Intravascular leukaggregation, abnormal red blood cell deformability, increased microvascular permeability, interstitial protein loss, and tissue edema are frequently observed (4). These changes are promoted by proinflammatory mediators and are partly modulated by the endothelium. It is hypothesized that endothelial injury exacerbates maldistribution of regional blood flow and leads to cellular hypoxia and vital organ dysfunction.
In patients with sepsis, intravenous fluids and inotrope administration are widely used to support the systemic circulation. Although these interventions may reverse latent intravascular hypovolemia and improve myocardial contractility, there are few data regarding their effects on tissue oxygen tension (PtO2), and they have not been associated with any survival benefit in patients with septic shock. Clinically, a hyperdynamic circulatory response to fluid resuscitation is observed. Second, peripheral vasodilatation and systemic hypotension are characteristic features of severe sepsis and despite reflex increases in cardiac output are associated with impairment of left ventricular function (5). The endogenous vasodilator nitric oxide (NO), formed from the substrate L-arginine by NO synthase (NOS), is reported to play a major role in the cardiovascular response to sepsis (6). Potential beneficial effects of NOS inhibition in animal models and clinical sepsis have been the subject of considerable speculation (7, 8), but there are no studies investigating the effects of generalized NOS inhibition on peripheral tissue oxygenation. Thus, any improvements in systemic hemodynamic indices may be complicated by impaired tissue nutrition, in addition to other theoretical disadvantages (9).
We have demonstrated recently that significant tissue hypoxia and abnormal microvascular regulation of tissue oxygenation occur in endotoxemic rats, despite apparently normal microcirculatory perfusion (10). The aims of this study were fourfold: first, to further assess global hemodynamic performance (and thus oxygen delivery), gas exchange, and PtO2 in a rodent model of endotoxemia; second, to examine the effect of fluid resuscitation on these parameters in endotoxemic rats; third, to examine the effects of generalized NOS inhibition on these parameters, in the presence and absence of endotoxemia; and finally, to examine the combined effect of fluid resuscitation and generalized NOS inhibition on these parameters in the presence and absence of endotoxemia.
| |
METHODS |
|---|
|
|
|---|
Animals and Anesthesia
All procedures and protocols were performed in accordance with the
Animal (Scientific Procedures) Act, 1986, and approved by the Home
Office (UK) Inspectorate. Male Wistar rats (275-300 g) received Salmonella enteritidis (Sigma Chemical, Poole, UK) endotoxin (20 mg · kg
1, intraperitoneally) or saline vehicle (3 ml · kg
1, intraperitoneally)
3.5 h before anesthesia with pentobarbitone (60 mg · kg
1, intraperitoneally). Animals were placed supine on an electric heating pad,
maintaining body temperature between 36 and 37° C. A cannula was
inserted into the left femoral artery and attached to a pressure transducer (Hewlett-Packard, Bracknell, UK) for continuous mean arterial
blood pressure (MAP) monitoring and withdrawal of blood samples.
A 1-Fr thermistor microprobe (Columbus Instruments, OH) was inserted into the aortic arch via the right carotid artery.
A tracheostomy was performed, and the animals ventilated using a
mixture of 21% O2, 5% CO2, and balance N2 using a volume-cycled, small animal ventilator (Harvard Apparatus, Chatham, Kent, UK). A
cannula was inserted into the right atrium via the right jugular vein,
and attached to a microinjector (Columbus Instruments, Columbus, OH) allowing 150 µl injection of room-temperature saline. Thermistor cardiac output (CO) was measured (Cardiotherm 500 AC-R
cardiac output computer; Columbus Instruments), and the mean of
two consecutive measurements within 10% of each other recorded.
The left jugular vein was cannulated to permit volume resuscitation in
appropriate animals; 4 ml · kg
1 · body wt
1 bolus of 0.9% saline being administered after placement of the cannulae, followed by an infusion of 16 ml · h
1 · kg
1 · body wt
1. Intermittent boluses of intraperitoneal pentobarbitone were given to supplement anesthesia as required.
Microelectrodes
Techniques for measuring PtO2 using gold disk microelectrodes are described elsewhere (10). Briefly, gold disk electrodes (125 µM) embedded in 25-gauge hypodermic needles were constructed in our laboratory. Current-voltage curves were constructed over the range 0 to
1.2 V to determine appropriate polarizing voltages. Electrodes were
calibrated before and after each experiment with air-equilibrated and
nitrogen-sparged saline. Electrodes were polished between experiments with alumina to remove adsorbed protein, and were ultrasonicated for 15 min in deionized water before recalibration. Electrodes
were polarized using a two-channel potentiostat (EMS Instruments,
Oxford, UK). The resulting raw current was sampled at 30 Hz with a
personal computer (Dell Latitude LX 4100; Dell, Bracknell, Berkshire, UK), using a data acquisition board (Data Shuttle; Strawberry
Tree, Sunnyvale, CA), and processed by data acquisition software
(Workbench for Windows; Strawberry Tree).
Experimental Protocols
The microelectrodes were carefully inserted into the rectus femoralis
muscle to a depth of ~ 3 mm. Initial polarization of the microelectrodes was followed by an equilibration period of 20 min. Fraction of
inspired oxygen (FIO2) was altered every 10 min in the sequence; baseline (0.21)
0.5
0.21
0.1
0.21
0.95 while continuous measurements of PtO2 and MAP were made. The two 0.21 FIO2 sequences
after baseline (0.21 FIO2) were included as an equilibration period during which PtO2 could return to baseline (i.e., 0.21 FIO2) values. CO
measurements and arterial blood gases (MODLE) were measured at
the midpoint of ventilation with 0.21 (baseline), 0.5, 0.1, and 0.95 FIO2.
Animals were divided at random into the following groups:
Experiment 1: Effects of endotoxemia. Sham-treated animals (Group 1, n = 5) and endotoxemic animals (Group 2, n = 5).
Experiment 2: Effect of volume resuscitation. Sham-resuscitated animals (Group 3, n = 5) and endotoxemic-resuscitated animals (Group 4, n = 5). Resuscitation commenced 10 min prior to baseline recording.
Experiment 3: Effect of NG-nitro-L-arginine methyl ester (L-NAME)
(1 mg · kg
1, intravenous bolus). Sham-L-NAME animals (Group 5, n = 5) and endotoxemic-L-NAME animals (Group 6, n = 6). L-NAME
was administered 10 min prior to baseline recording.
Experiment 4: Effect of combined L-NAME (1 mg · kg
1, intravenous bolus) and volume resuscitation. Sham-resuscitated-L-NAME animals (Group 7, n = 5) and endotoxemic-resuscitated-L-NAME animals (Group 8, n = 6). L-NAME was administered simultaneously
with volume resuscitation 10 min prior to baseline recording.
Data Analysis
All results are expressed as mean ± SEM. Multiple group comparisons were analyzed using a one-way nonparametric analysis of variance (ANOVA) followed by Student-Newman-Keuls post-test to isolate differences. Differences between individual group means were
tested by a Student's unpaired t test. Values of p
0.05 were considered significant.
| |
RESULTS |
|---|
|
|
|---|
Experiment 1: Effect of Endotoxemia
No significant differences in MAP or PaCO2 were observed at baseline, nor throughout the experimental period (Table 1 and Figure 1A). CO was similarly unchanged at baseline, although a significant decrease was observed in endotoxin-treated animals (Table 1, Group 2) at 0.1 FIO2 (Figure 1B). A significant metabolic acidosis was observed in the lipopolysaccharide (LPS)-treated animals and this persisted throughout the experimental period (Figure 1C). Although PaO2 was normal at baseline in endotoxemic animals, mean muscle PtO2 was significantly depressed compared with sham-treated rats (Table 1 and Figures 1D and 1E). Significant impairment of the muscle PtO2 response to hyperoxia was observed in endotoxemic animals at 0.5 and 0.95 FIO2 (Figure 1D).
|
|
Experiment 2: Effect of Volume Resuscitation
Volume-resuscitated rats (Group 3) displayed no differences in CO, blood pH, PaO2, PaCO2, or muscle PtO2 compared with sham-treated animals (Group 1) at baseline (Table 1) or during the experiment (data not shown). MAP was unchanged at baseline, but a significant rise was observed at 0.95 FIO2 (140 ± 2.1 versus 119 ± 2.7 mm Hg; p < 0.01). In volume-resuscitated LPS-treated rats (Group 4), no significant differences in PtO2, MAP, CO, PaO2, or pH were observed at baseline compared with sham-treated rats (Table 1 and Figures 1A-1E), although PaCO2 was lower at baseline and at 0.1 FIO2 (Figure 1F). PtO2 was unchanged at baseline and throughout the experiment (Table 1 and Figure 1D). A significant difference in PtO2 between volume-resuscitated and nonvolume-resuscitated endotoxemic-treated rats was observed at 0.95 FIO2 (Figure 1D). Similarly, no significant differences in CO nor pH were observed at baseline nor throughout the experiment compared with sham-treated rats (Table 1 and Figures 1B and 1C). MAP was also unaltered at baseline, but was significantly different from LPS-treated rats at 0.1 FIO2 (Table 1 and Figure 1A). PaO2 was unchanged throughout (Figure 1E).
Experiment 3: Effect of L-NAME
L-NAME alone (Group 5) caused a significant increase in MAP, and a significant fall in CO at baseline compared with sham-treated rats (Table 1 and Figures 2A and 2B). This effect was sustained throughout the experiment, with a significant fall in CO at all FIO2 (Figure 2B), coupled with a significant increase in MAP at 0.95 FIO2 (Figure 2A). PtO2 was unchanged at baseline, but was significantly reduced at 0.5 and 0.95 FIO2 (Table 1 and Figure 2D). Blood pH and PaCO2 were unchanged at baseline and throughout the experiment (Table 1 and Figures 2C and 2F). Blood PaO2 was significantly reduced at baseline and 0.95 FIO2 (Table 1 and Figure 1E).
|
In L-NAME-treated LPS animals (Group 6), no significant differences in MAP nor CO were observed at baseline (Figures 2A and 2B). MAP did not change throughout the experiment, whereas CO was significantly reduced at 0.95 FIO2 only (Figures 2A and 2B). PtO2 was unchanged at baseline, but was significantly reduced at 0.5 and 0.95 FIO2 (Table 1 and Figure 2D). Blood pH was also significantly reduced at baseline and 0.1 FIO2 (Table 1 and Figure 2C). PaCO2 was significantly reduced at baseline, but was unchanged throughout the experiment (Figure 2F), whereas PaO2 was unchanged throughout (Figure 2E).
Experiment 4: Effect of Combined L-NAME and Volume Resuscitation
Sham-resuscitated-L-NAME rats (Group 7) displayed no significant differences in CO or MAP at baseline compared with sham control rats (Group 1), whereas a significant difference in MAP was observed at 0.1 FIO2 only (Figures 3A and 3B). Moreover, PtO2 (Figure 3D), PaO2, and PaCO2 (Figures 3E and 3F) were unchanged both at baseline, and throughout the experiment. By contrast, blood pH was significantly lower at baseline and throughout the experiment (Figure 3C). In endotoxin-treated, volume-resuscitated, L-NAME rats (Group 8), no significant differences in MAP were observed compared with sham control rats (Group 1), whereas a significant fall in CO was detected at 0.1 FIO2 only (Figures 3A and 3B). Moreover, both PaO2 and PaCO2 were unchanged throughout (Figures 3E and 3F). PtO2 was unchanged at baseline, but significantly reduced at 0.5 and 0.95 FIO2 (Figure 3D) compared with sham control rats (Group 1). Blood pH was significantly reduced at baseline and throughout the experiment (Figure 3C).
|
| |
DISCUSSION |
|---|
|
|
|---|
We have previously shown significant tissue hypoxia and abnormal microvascular regulation in endotoxemic rats, even in the presence of normal microcirculatory perfusion (10). Using the same model, we have now examined the relationship between tissue oxygenation and systemic hemodynamic changes by also measuring cardiac output; and have investigated the effects of volume resuscitation and NOS inhibition on this relationship. The data presented are in accord with our previous study in that significant tissue hypoxia was observed in endotoxemic muscle compared with sham-treated animals (10). PtO2 was similarly resistant to increasing FIO2. These peripheral changes were accompanied by a decrease in blood pH, although MAP and CO were maintained. However, it has been previously shown that persistent metabolic acidosis may not represent tissue hypoxia, and thus the fall in blood pH observed may not reflect altered O2 delivery (11). Previous studies investigating the state of tissue oxygenation in endotoxemic and other models of sepsis have produced varying results (10). In porcine hypotension, impaired oxygenation is observed in skeletal muscle only in the latter stages of the condition (12), whereas in rabbit muscle, the effects are extremely rapid in onset (13). Conversely, another study demonstrated elevated PtO2 in the endotoxemic rat bladder epithelium, indicating that changes in tissue oxygenation may be species and/ or organ-specific (14). Recently, muscle PtO2 in patients with septic shock has been shown to be lower than in control subjects (15). By contrast, others have found that mean PtO2 in patients with sepsis/septic shock was significantly elevated compared with those with "limited infection" or cardiogenic shock (16). However, neither investigator considered the effects of the administration of inotropic drugs, which are known to elevate PtO2 (17).
Patients with sepsis frequently require volume resuscitation, although few data exist regarding its effects on endotoxemia-induced tissue hypoxia. In rats with peritonitis, volume resuscitation reverses the observed fall in both PtO2 and cardiac output (18), although experiments with dogs suggest the reversibility is organ-specific (19). Our current data demonstrate that volume resuscitation can reverse the effects of endotoxemia on PtO2, without affecting hemodynamics. Our model displayed a normodynamic circulation, suggesting that fluid deficit was limited to the peripheral microcirculation only. Another possibility was that the hypoxia observed in the endotoxemic animals represented a redistribution of blood flow from the muscle to more vital organs. This seems unlikely however, as we have previously demonstrated in this model that nutritive muscle blood flow appears to be normal in endotoxemic animals, indicating possible impaired cellular oxygen extraction (10). Further studies will be needed to examine changes in flow at the level of the microcirculation, and the mechanism of action by which volume resuscitation improves tissue oxygenation in this model. Irrespective of this, and coupled with the partial reversal of the acidemia, our data emphasize the clinical importance of adequate fluid resuscitation in sepsis.
The role of NO in modulating the vascular response to sepsis is recognized, but poorly understood. Under physiological circumstances, NO is produced by a constitutive isoform of NOS, and appears to be essential in the maintenance of vascular tone and the regulation of organ blood flow (20). Bacterial LPS and several mediators of the immunogenic response to gram-positive and gram-negative organisms stimulate the production of the inducible form of NOS (iNOS) in a number of tissues, including macrophages, endothelium, and vascular smooth muscle (6). Immunostimulation results in iNOS induction and the largely unregulated release of NO. Many studies have shown increased expression of iNOS and increased levels of NO in both animal models and patients with sepsis (7, 21, 22).
Beneficial effects of generalized NOS inhibition in sepsis have been reported. NOS inhibition normalized cardiac index and systemic vascular resistance, MAP, and decreased heart rate without impairing oxygen consumption in unanesthetized sheep with hyperdynamic sepsis (23). In murine endotoxemia, neither NOS inhibition nor antibiotics alone altered mortality, but coadministration of the two treatments significantly improved survival (24). NOS inhibition increases blood pressure and systemic vascular resistance in patients with severe septic shock (8) and does not limit skeletal muscle O2 uptake in the hindlimb, despite decreased blood flow (25). By contrast, several studies have demonstrated a potentially detrimental effect of generalized NOS inhibition in sepsis. Thus, in porcine endotoxemia, L-NAME reduced venous return and increased left ventricular afterload, which could compromise cardiovascular function (26). Furthermore, NOS inhibition has decreased survival time in a murine model of sepsis (27). L-NAME has also been shown to impair tissue oxygen extraction in the canine mesenteric circulation (28). Further, in the same model rendered endotoxemic, NOS inhibition did not improve critical oxygen extraction ratios, despite improved hemodynamic performance (28). However, there are no data regarding the effects of generalized NOS inhibition on skeletal muscle tissue oxygenation. Our study demonstrates that L-NAME alone causes significant tissue hypoxia, possibly due to the accompanying fall in cardiac output and arterial oxygen tension. Alternatively, L-NAME may have increased shunt. However, this is unlikely, as we have previously demonstrated that both selective and nonselective NOS inhibition augment hypoxic pulmonary vasoconstriction in this model (29, 30). Not surprisingly, L-NAME had no beneficial effect on PtO2 in endotoxemic animals. One possibility is that the tissue hypoxia observed in endotoxemic animals was caused by impaired oxygen uptake, as discussed earlier, whereas the tissue hypoxia induced by L-NAME alone was caused by redistribution of blood flow. Moreover, administration of L-NAME together with volume resuscitation attenuated the beneficial effects of resuscitation alone on the endotoxemic-induced changes in tissue oxygenation described previously. By contrast, recent experiments have demonstrated that specific inhibition of iNOS, rather than generalized inhibition, improves mortality in animal models of endotoxemia (31, 32). These, together with our observations raise important questions about the potential clinical benefits of generalized NOS inhibition. Further experiments using specific iNOS inhibitors will be required to fully understand the role of NO in sepsis.
In summary, this study indicates that significant skeletal muscle hypoxia is a complication of experimental endotoxemia in the rat. In this model, impaired tissue microvascular control was present, and was not improved by increasing FIO2. These changes were reversed by volume resuscitation, emphasizing the potential clinical importance of this maneuver. NOS inhibition alone induced a significant fall in PtO2 and did not improve tissue oxygenation in endotoxemia. Lastly, coadministration of volume resuscitation and NOS inhibition did not improve tissue oxygenation, indicating that the beneficial effects of fluid resuscitation described above were nullified by L-NAME. Further investigation into the effects of generalized NOS inhibition on tissue oxygenation is required to assess the overall clinical importance of this approach to treating patients with sepsis.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Professor Timothy W. Evans, Unit of Critical Care, Royal Brompton Hospital, London SW3 6LY, UK.
(Received in original form January 30, 1998 and in revised form August 10, 1998).
P.B.A. is supported by the British Heart Foundation.| |
References |
|---|
|
|
|---|
1.
Centers for Disease Control.
1990.
Increase in national hospital discharge survey rates for septicemia
United States, 1979-1987.
M.M.W.R.
39:
31-34
.
[Medline]
2. St. John, R. C., and P. M. Dorinsky. 1994. An overview of multiple organ dysfunction syndrome. J. Lab. Clin. Med. 124: 478-483 [Medline].
3.
Myers, P. R.,
Q. Zhong,
J. J. Jones,
M. A. Tanner,
H. R. Adams, and
J. L. Parker.
1995.
Release of EDRF and NO in ex vivo perfused
aorta: inhibition by in vivo E. coli endotoxemia.
Am. J. Physiol.
268:
H955-H961
4. Curzen, N. P., M. J. Griffiths, and T. W. Evans. 1994. Role of the endothelium in modulating the vascular response to sepsis [Editorial]. Clin. Sci. Colch. 86: 359-374 [Medline].
5. Bunnell, E., and J. E. Parrillo. 1996. Cardiac dysfunction during septic shock. Clin. Chest Med. 17: 237-248 [Medline].
6. Payen, D., C. Bernard, and S. Beloucif. 1996. Nitric oxide in sepsis. Clin. Chest Med. 17: 333-350 [Medline].
7. Liu, S., I. M. Adcock, R. W. Old, P. J. Barnes, and T. W. Evans. 1993. Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA. Biochem. Biophys. Res. Commun. 196: 1208-1213 [Medline].
8. Petros, A., D. Bennett, and P. Vallance. 1991. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock [see comments]. Lancet 338: 1557-1558 [Medline].
9. Griffiths, M. J., N. P. Curzen, M. Sair, and T. W. Evans. 1994. Nitric oxide synthase inhibitors in septic shock: theoretical considerations. Clin. Int. Care 5: 29-36 .
10.
Sair, M.,
P. J. Etherington,
N. P. Curzen,
C. P. Winlove, and
T. W. Evans.
1996.
Tissue oxygenation and perfusion in endotoxemia.
Am.
J. Physiol.
271:
H1620-H1625
11. Fink, M. P.. 1996. Does tissue acidosis in sepsis indicate tissue hypoperfusion? Intensive Care Med. 22: 1144-1146 [Medline].
12. Kopp, K. H., E. Sinagowitz, and H. Muller. 1984. Oxygen supply of skeletal muscle in experimental endotoxic shock. Adv. Exp. Med. Biol. 169: 467-476 [Medline].
13.
Gutierrez, G.,
N. Lund, and
F. Palizas.
1991.
Rabbit skeletal muscle PO2
during hypodynamic sepsis.
Chest
99:
224-229
14.
Rosser, D. M.,
R. P. Stidwill,
D. Jacobson, and
M. Singer.
1995.
Oxygen
tension in the bladder epithelium rises in both high and low cardiac
output endotoxemic sepsis.
J. Appl. Physiol.
79:
1878-1882
15. Reinhart, K., F. Bloos, F. Konig, L. Hannemann, and B. Kuss. 1990. Oxygen transport variables and muscle tissue oxygenation in critically ill patients with and without sepsis. Adv. Exp. Med. Biol. 277: 861-864 [Medline].
16. Boekstegers, P., S. Weidenhofer, T. Kapsner, and K. Werdan. 1994. Skeletal muscle partial pressure of oxygen in patients with sepsis. Crit. Care Med. 22: 640-650 [Medline].
17. Lund, N., R. J. de Asla, F. Cladis, P. J. Papadakos, and P. A. Thorborg. 1995. Dopexamine hydrochloride in septic shock: effects on oxygen delivery and oxygenation of gut, liver, and muscle. J. Trauma 38: 767-775 [Medline].
18. Astiz, M., E. C. Rackow, M. H. Weil, and W. Schumer. 1988. Early impairment of oxidative metabolism and energy production in severe sepsis. Circ. Shock 26: 311-320 [Medline].
19.
Vallet, B.,
S. E. Curtis,
M. J. Winn,
C. E. King,
C. K. Chapler, and
S. M. Cain.
1994.
Hypoxic vasodilation does not require nitric oxide (EDRF/
NO) synthesis.
J. Appl. Physiol.
76:
1256-1261
20. Moncada, S., R. M. Palmer, and E. A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43: 109-142 [Medline].
21. Liu, S. F., I. M. Adcock, R. W. Old, P. J. Barnes, and T. W. Evans. 1994. Differential regulation of the constitutive and inducible nitric oxide synthase mRNA by lipopolysaccharide treatment in vivo in the rat. Crit. Care Med. 24: 1219-1225 .
22.
Griffiths, M. J.,
S. Liu,
N. P. Curzen,
M. Messent, and
T. W. Evans.
1995.
In vivo treatment with endotoxin induces nitric oxide synthase in rat
main pulmonary artery.
Am. J. Physiol.
268:
L509-L518
23.
Meyer, J.,
F. Hinder,
J. Stothert Jr.,
L. D. Traber,
D. N. Herndon,
J. T. Flynn, and
D. L. Traber.
1994.
Increased organ blood flow in chronic
endotoxemia is reversed by nitric oxide synthase inhibition.
J. Appl.
Physiol.
76:
2785-2793
24.
Teale, D. M., and
A. M. Atkinson.
1992.
Inhibition of nitric oxide synthesis improves survival in a murine peritonitis model of sepsis that is
not cured by antibiotics alone.
J. Antimicrob. Chemother.
30:
839-842
25.
King, C. E.,
M. J. Melinyshyn,
J. D. Mewburn,
S. E. Curtis,
M. J. Winn,
S. M. Cain, and
C. K. Chapler.
1994.
Canine hindlimb blood flow and
O2 uptake after inhibition of EDRF/NO synthesis.
J. Appl. Physiol.
76:
1166-1171
26.
Saetre, T.,
O. A. Smiseth,
T. Scholz,
H. Carlsen,
L. Nordsletten,
E. Fahlstrom, and
A. O. Aasen.
1996.
Nitric oxide synthase inhibition reduces
venous return in porcine endotoxemia.
Am. J. Physiol.
271:
H1325-H1332
27. Spain, D. A., M. A. Wilson, M. F. Bar, Natan, and R. N. Garrison. 1994. Nitric oxide synthase inhibition aggravates intestinal microvascular vasoconstriction and hypoperfusion of bacteremia. J. Trauma 36: 720-725 [Medline].
28. Schumacker, P. T., J. Kazaglis, H. V. Connolly, R. W. Samsel, M. F. O'Connor, and J. G. Umans. 1995. Systemic and gut oxygen extraction during endotoxemia: role of nitric oxide synthesis. Am. J. Respir. Crit. Care Med. 151: 107-115 [Abstract].
29.
Griffiths, M. J. D.,
N. P. Curzen,
J. A. Mitchell, and
T. W. Evans.
1997.
In vitro treatment with endotoxin increases rat pulmonary vascular
contractility despite NOS induction.
Am. J. Respir. Crit. Care Med.
156:
654-658
30. Liu, S. F., D. E. Crawley, P. J. Barnes, and T. W. Evans. 1991. Endothelium-derived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats. Am. Rev. Respir. Dis. 143: 32-37 [Medline].
31. Wu, C. C., S. J. Chen, C. Szabo, C. Thiemermann, and J. R. Vane. 1995. Br. J. Pharmacol. 114: 1666-1672 [Medline].
32. Liaudet, L., F. Feihl, A. Rosselet, M. Markert, J. M. Hurni, and C. Perret. 1996. Clin. Sci. Colch. 90: 369-377 [Medline].
This article has been cited by other articles:
![]() |
R. M. Bateman, C. Tokunaga, T. Kareco, D. R. Dorscheid, and K. R. Walley Myocardial hypoxia-inducible HIF-1{alpha}, VEGF, and GLUT1 gene expression is associated with microvascular and ICAM-1 heterogeneity during endotoxemia Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H448 - H456. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Goldman, R. M. Bateman, and C. G. Ellis Effect of decreased O2 supply on skeletal muscle oxygenation and O2 consumption during sepsis: role of heterogeneous capillary spacing and blood flow Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2277 - H2285. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Goldman, R. M. Bateman, and C. G. Ellis Effect of sepsis on skeletal muscle oxygen consumption and tissue oxygenation: interpreting capillary oxygen transport data using a mathematical model Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2535 - H2544. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Ellis, R. M. Bateman, M. D. Sharpe, W. J. Sibbald, and R. Gill Effect of a maldistribution of microvascular blood flow on capillary O2 extraction in sepsis Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H156 - H164. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hausladen, A. Gow, and J. S. Stamler Flavohemoglobin denitrosylase catalyzes the reaction of a nitroxyl equivalent with molecular oxygen PNAS, August 17, 2001; (2001) 181199698. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. SINGH, S J. WORT, and T. W EVANS Inducible nitric oxide and pulmonary infection Thorax, November 1, 1999; 54(11): 959 - 960. [Full Text] |
||||
![]() |
A. Hausladen, A. Gow, and J. S. Stamler Flavohemoglobin denitrosylase catalyzes the reaction of a nitroxyl equivalent with molecular oxygen PNAS, August 28, 2001; 98(18): 10108 - 10112. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |